Polestar (Nasdaq: PSNY) expects to publish the fourth quarter select and full-year 2025 consolidated financial results on 17 April 2026, before market open. Management will host a conference call at ...

The error “Column is invalid in the select list because it is not contained in either an aggregate function or the GROUP BY clause” appears when a query uses ...

Every time someone orders food online, checks exam results, or streams a video, new data is created and saved. Behind these activities are large databases that store millions of records. These ...

At Power for Tomorrow, we track how U.S. utilities adapt to challenges like artificial intelligence and data centers — sharing what works to keep power reliable and affordable. That’s why we’re ...

Mutual fund feeds and expenses are charges that may be incurred by investors who hold mutual funds. Running a mutual fund involves costs, including shareholder transaction costs, investment advisory ...

If you use Excel 40 hours a week (and those are the weeks you are on vacation), welcome to the MrExcel channel. Home to 2,400 free Excel tutorials. Bill "MrExcel" Jelen is the author of 67 books about ...

Community driven content discussing all aspects of software development from DevOps to design patterns. The key difference between columns and rows is that a column arranges data vertically from top ...

Have you ever poured hours into crafting a Power BI report only to realize your charts are, well, uninspiring? You’re not alone. While Power BI column charts are a staple for visualizing data, their ...

During the Karen Read retrial Wednesday, a cell phone data expert testified about a controversial timestamp tied to the case. Read is accused of killing her boyfriend, Boston police Officer John ...

When Densu Dixon, 26, went on his first date with a woman he met on Tinder, he assumed she would be paying for her share of dinner and drinks that night. Instead, he found himself footing the bill for ...

Arrowhead Pharmaceuticals’ phase 1/2a study has found the company’s investigational RNA interference (RNAi) candidate was generally well tolerated among 14 patients with kidney disease. The “select” ...